OptraSCAN launches OS-SiA, a next-gen AI-enabled digital scanner
OptraSCAN, the end-to-end digital pathology solution provider, announced the launch of OS-SiA, a new generation AI-enabled digital scanner that automatically identifies regions to SCAN and simultaneously analyses the tissue or cell area being scanned. OS-SiA is claimed to be industry’s first AI-driven digital scanner that will provide real-time predictive analysis and actionable insights, ever discovered.
“Digital Pathology scanners found in the market are restricted to partial/whole slide image acquisition and digitisation of slide into an image. To overcome all these challenges, the thought of inventing a next-gen scanner – OS-SiA was born; wherein AI based classification modules and complex image processing algorithms are embedded in the scanner itself, eliminating the need of additional processing applications,” said Abhi Gholap, founder & CEO, OptraSCAN. “The objective of introducing OS-SiA is to ease the work of histopathologists so they can view the scanned/digitised image along with analysed output as overlay during their review process,” he further added.
OS-SiA scanners are highly flexible and customisable scanners that can be embedded in OptraSCAN’s existing series of cloud-enabled 15-120 slide brightfield scanners namely OS-15 & OS-120. The analysed information acts as a reference heatmap, guiding the end users to get a high level view of the tumor, rare events, or any other areas of importance. The digitised images taken from OS-SiA can be viewed in local, web based, mobility-based image viewer.
“It’s no denying that Pathology today has transitioned to a next level, all owing to the technology advancements. OptraSCAN is a front-runner of this movement and has proven that time and again. OS-SiA scanner, driven by artificial intelligence, is one such innovative creation that is specifically designed keeping in mind the ease of operation for the pathologists,” opined Dr. Jiaoti Huang, chair – Pathology at Duke University & chairman of OptraSCAN’s Medical Advisory Board.
Elated on launching this invention, Dr. Clive Taylor, chief medical officer, OptraSCAN said, “AI-based products & solutions have great potential to improve patient outcomes and augment efficiency. I am glad that OptraSCAN has shown great strides in developing futuristic digital pathology products and solutions that can be automated, in-turn helping the pathologists in providing accurate assessments.”
Comment on this article below or via Twitter @IoTGN